-transparent.png){kind=logo}
Ranitidine, 300 mg daily, was given to 92 patients with duodenal ulcer (DU), 38 with prepyloric ulcer (PPU), and 21 with gastric corporeal ulcer (GCU). The healing rates at 4 weeks differed for the different types of ulcers (P less than 0.01), being 91% for DU, 68% for PPU, and 81% for GCU. After established ulcer healing, maintenance treatment with either ranitidine, 100 mg twice daily or 150 mg at night, or placebo was given for 1 year or until ulcer relapse in a total of 108 patients--71 with DU, 24 with PPU, and 13 with GCU. There were no significant differences in relapse rates between the two groups treated with active drug or between the three ulcer groups. However, the overall relapse rate in the active drug groups was 16%, against 72% in the placebo group (P less than 0.001).
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
November 1982,
Lancet (London, England),
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
July 1994,
Journal of gastroenterology,
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
January 1986,
Klinische Wochenschrift,
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
September 1985,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
October 1955,
Revista brasileira de medicina,
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
August 1988,
Journal of clinical gastroenterology,
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
January 1989,
Scandinavian journal of gastroenterology. Supplement,
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
May 1983,
Gut,
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
December 1999,
Canadian journal of gastroenterology = Journal canadien de gastroenterologie,
G Liedberg, and
H J Davies, and
L Enskog, and
S Eriksson, and
B Frederiksen, and
H Graffner, and
M Hradsky, and
J Oscarson, and
B Rydberg, and
G Simert
March 1978,
Lancet (London, England),
